Arbor Vita Corporation
Biotechnology ResearchCalifornia, United States11-50 Employees
Arbor Vita Corporation is a privately held biotechnology research company based in Fremont, California. It focuses on enabling early and accurate diagnosis and treatment of disease, with products that are on the market or in clinical studies addressing global health challenges such as HPV-induced cancer and infectious diseases. The company maintains a development pipeline, reflecting ongoing work to expand its diagnostic and clinical options. It serves healthcare providers and public health applications seeking improved diagnostic tools and treatment decisions in its areas of focus. Positioned in the biotechnology research industry, Arbor Vita operates across diagnostics and infectious disease portfolios with multiple development efforts. In June 2020, the company announced the launch of its CoVisa IgG ELISA-based test for antibodies associated with the novel coronavirus.